Perfect Medical Health Management Limited (HKG:1830)
Hong Kong
· Delayed Price · Currency is HKD 1.800
+0.020 (1.12%)
Jun 25, 2025, 4:08 PM HKT
HKG:1830 Revenue
Perfect Medical Health Management had revenue of 620.27M HKD in the half year ending September 30, 2024, a decrease of -7.19%. This brings the company's revenue in the last twelve months to 1.30B, down -9.98% year-over-year. In the fiscal year ending March 31, 2024, Perfect Medical Health Management had annual revenue of 1.39B with 0.29% growth.
Revenue (ttm)
1.30B
Revenue Growth
-9.98%
P/S Ratio
1.73
Revenue / Employee
1.12M
Employees
1,273
Market Cap
2.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1.39B | 4.08M | 0.29% |
| Mar 31, 2023 | 1.39B | 39.29M | 2.91% |
| Mar 31, 2022 | 1.35B | 260.20M | 23.88% |
| Mar 31, 2021 | 1.09B | -151.18M | -12.18% |
| Mar 31, 2020 | 1.24B | 43.92M | 3.67% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |
| Akeso | 2.26B |